Holiday pricing through Dec 25, 2026: 20% off single-grant packages, 25% off annual programs. See pricing

Serving clients in the US, UK and Australia+1 (844) 400-0525

US grant · National Institutes of Health

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Up to $200,000 Closes November 17, 2026

Official listing and how to apply Full funding notice

Source: Grants.gov · Last checked

Key facts

FunderNational Institutes of Health
Part ofDepartment of Health and Human Services
Opportunity numberPAR-25-096
Amount per awardUp to $200,000
Total funding available$200,000
OpensNovember 18, 2024
ClosesNovember 17, 2026 (7 days left)
Who can applySchools and universities, Businesses, Government, Nonprofits, Other (see listing), Tribal organizations
Applicant types listedCounty governments; Public and State controlled institutions of higher education; Small businesses; Private institutions of higher education; For profit organizations other than small businesses; City or township governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; Public housing authorities/Indian housing authorities; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal governments (Federally recognized); Independent school districts; Native American tribal organizations (other than Federally recognized tribal governments)
State or areaNationwide
Cost sharing or matchNot required
StatusOpen
SourceGrants.gov
Last checkedNovember 10, 2026

About this grant

Summary from the official listing on Grants.gov:

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Details are copied from the official source and can change. Check the official listing before you apply. Grant Writing Company is not affiliated with this funder.

Want an expert to write it with you?

Grant Writing Company researches funders, writes organization proposals to each funder's instructions, and checks the package before you submit. experience since 2006. Funders decide every award.

Book a free call See our services